Efficacy of 2-DG intervention in COVID-19 as assessed by 6-Minute Walk Test: A case series

Vigg A , Anuradha K


Purpose: To evaluate the effect of 2-deoxy-D-glucose (2-DG) and its impact on the 6-minute walk test (6MWT) in COVID-19 patients before hospital discharge.

Methods: The 6MWT report of the patients hospitalized with acute COVID-19 were analyzed retrospectively. All enrolled patients received 2-DG therapy as an adjunct for ten days to the standard of care in the management of COVID-19. A 6MWT was performed to determine any possible cases of silent hypoxemia before and after 2-DG administration. Data obtained during the tests were compared to evaluate the effect of 2-DG on the clinical condition of the patients and improvement in 6MWT.

Results: A significant improvement in the mean heart rate (86.5 ± 5.6/min, 91.1 ± 5.7/min), Borg scale breathlessness score (2.0 ± 0.5, 2.6 ± 0.7), and fatigue score (1.8 ± 0.6, 2.9 ± 0.6) was observed during the 6MWT post-2-DG therapy. Additionally, an optimum SpO2 level of > 95 % was achieved and maintained post-2-DG therapy compared to the baseline SpO2 level (< 90 %) pre-2-DG therapy. Improvement in these clinical parameters demonstrated a considerable improvement in the mean walking distance by 85% during the 6MWT with a marked development in the number of laps, speed, and metabolic equivalent (METS) compared to results obtained before 2-DG therapy.

Conclusion: 2-DG, as an adjunct therapy improved the clinical condition by achieving an optimum oxygen saturation level (> 95 %) in moderate to severely ill COVID-19 patients. It exhibited a positive impact on the 6MWT by improving the mean walking distance. 6MWT may be useful and can be considered as an effective tool to differentiate the hypoxemic patients before hospital discharge.

More Publications

Omalizumab for IgE-mediated food allergy: A systematic review and meta-analysis

Zuberbier T , Wood RA , Bindslev-Jensen C , Fiocchi A , Chinthrajah S , Worm M , Deschildre A , Rivas MF , Santos A , Jaumont JX , Tassinari P

Dec, 2022

The Journal of Allergy and Clinical Immunology: In Practice

Efficacy and safety of bisoprolol compared to other selective beta-1 blockers in the treatment of hypertension: a systematic review and meta-analysis of randomized parallel clinical trials

U Jadhav , T Nair , S Bansal , S Ray

Oct, 2021

European Heart Journal

Effect of omalizumab on glucocorticoid use and lung function in the treatment of allergic bronchopulmonary aspergillosis in people with cystic fibrosis: a systematic review and meta-analysis

Meiling Jin , Jo A. Douglass , J. Stuart Elborn , Slawomir Lazarewicz , Xavier Jaumont , Meng Yan , Ritesh Agarwal, , William J. Calhoun,

Dec, 2022

The Journal of Allergy and Clinical Immunology